These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3848476)

  • 21. Aluminum and renal bone disease in Australia.
    Dunstan CR; Evans RA
    Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapy of aluminum overload (I).
    Pierides AM; Myli MP
    Contrib Nephrol; 1984; 38():65-77. PubMed ID: 6425013
    [No Abstract]   [Full Text] [Related]  

  • 23. Persisting aluminium-related bone disease after cadaveric renal transplantation.
    Nicholas JC; Dawes PT; Davies SJ; Freemont AJ
    Nephrol Dial Transplant; 1999 Jan; 14(1):202-4. PubMed ID: 10052510
    [No Abstract]   [Full Text] [Related]  

  • 24. Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge.
    Pierides AM; Frohnert PP
    Trans Am Soc Artif Intern Organs; 1981; 27():629-33. PubMed ID: 7331145
    [No Abstract]   [Full Text] [Related]  

  • 25. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 26. [Osteomalacia and severe backache as a complication of long-term intake of Novalucol].
    Fredstorp L; Eyrich R
    Lakartidningen; 1984 Feb; 81(5):359-60. PubMed ID: 6230495
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy of aluminium overload (II).
    Ackrill P; Day JP
    Contrib Nephrol; 1984; 38():78-80. PubMed ID: 6713902
    [No Abstract]   [Full Text] [Related]  

  • 28. Iatrogenic osteomalacia and myopathy due to phosphate depletion.
    Baker LR; Ackrill P; Cattell WR; Stamp TC; Watson L
    Br Med J; 1974 Jul; 3(5924):150-2. PubMed ID: 4843652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined hemofiltration and desferrioxamine treatment for aluminum induced osteomalacia.
    Barré PE; Prichard S
    Int J Artif Organs; 1986 May; 9(3):167-72. PubMed ID: 3733242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Osteomalacia from phosphate-binding substances (author's transl)].
    Emanuelli C; Borghi M; Pecchini F
    Ateneo Parmense Acta Biomed; 1975; 46(6):577-87. PubMed ID: 1222067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Causes of hyperaluminemia in patients maintained on hemodialysis].
    Balezina OA; Ermolenko VM; Bel'skii NK; Nebol'sina LA; Segel'man VS
    Ter Arkh; 1982; 54(7):85-6. PubMed ID: 7135231
    [No Abstract]   [Full Text] [Related]  

  • 33. Aluminum kinetics of the REDY system: a study of the impact of deferoxamine therapy.
    Culpepper CP; Cummings R; Westervelt FB; Savory J; Wills MR
    Trans Am Soc Artif Intern Organs; 1983; 29():76-80. PubMed ID: 6673321
    [No Abstract]   [Full Text] [Related]  

  • 34. Fracture osteomalacia, CAPD, and aluminium.
    Kingswood C; Banks RA; Bunker T; Harrison P; Mackenzie C
    Lancet; 1983 Jan; 1(8314-5):70-1. PubMed ID: 6129404
    [No Abstract]   [Full Text] [Related]  

  • 35. Iron and aluminum osteomalacia in hemodialysis patients.
    Pierides AM; Myli MP
    N Engl J Med; 1984 Feb; 310(5):323. PubMed ID: 6690959
    [No Abstract]   [Full Text] [Related]  

  • 36. Case report 294. Diagnosis: dialysis osteomalacia with response to desferrioxamine therapy.
    Xipell JM; Ham KN; Brown DJ; Dawborn JK
    Skeletal Radiol; 1984; 12(4):298-302. PubMed ID: 6505735
    [No Abstract]   [Full Text] [Related]  

  • 37. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deferoxamine and aluminum removal.
    Swartz RD
    Am J Kidney Dis; 1985 Nov; 6(5):358-64. PubMed ID: 3904429
    [No Abstract]   [Full Text] [Related]  

  • 39. Desferrioxamine and osteomalacia.
    Mudde AH; Roodvoets AP
    Lancet; 1982 Sep; 2(8298):608. PubMed ID: 6125750
    [No Abstract]   [Full Text] [Related]  

  • 40. [EEG pattern indicative of dialysis encephalopathy].
    Dobato JL; Caminero AB
    Neurologia; 1999 Jan; 14(1):35. PubMed ID: 10079690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.